Lucid Diagnostics Expands Direct Contracting Initiative with Multiple Programs Focused on Near-Term Revenue DriversPRNewsWire • 8h
PAVmed to Hold a Business Update Conference Call and Webcast on November 14, 2024PRNewsWire • 10/31/24
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 13, 2024PRNewsWire • 10/30/24
Lucid Diagnostics Receives Notice of Allowance for Key Patent Underlying Its EsoGuard Esophageal DNA TestPRNewsWire • 10/15/24
PAVmed Subsidiary, Veris Health, Awarded $1.8 Million NIH Grant to Enhance Cancer CarePRNewsWire • 10/10/24
American Foregut Society's 2024 Annual Meeting to Highlight Lucid Diagnostics' EsoGuard Esophageal Precancer TestPRNewsWire • 09/24/24
Lucid Diagnostics to Host Symposium on Non-Endoscopic Esophageal Precancer Screening at the 20th International Society for Diseases of the Esophagus (ISDE) World CongressPRNewsWire • 09/10/24
Lucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile HealthPRNewsWire • 09/03/24
Lucid Diagnostics Announces Publication of Analytical Validation Study of EsoGuard® for Early Detection of Esophageal Precancer and CancerPRNewsWire • 08/20/24
The American Foregut Society Formally Requests Medical Policy Coverage of EsoGuard® to Enhance Early Detection of Esophageal CancerPRNewsWire • 08/13/24
Lucid Diagnostics Provides Business Update and Second Quarter 2024 Financial ResultsPRNewsWire • 08/12/24
Lucid Diagnostics Holds First Major Directly-Contracted EsoGuard® #CheckYourFoodTube Precancer Testing EventPRNewsWire • 08/08/24
Lucid Diagnostics Announces Positive Data from ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer TestingPRNewsWire • 08/06/24
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 12, 2024PRNewsWire • 07/29/24
Lucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening PopulationPRNewsWire • 07/02/24
PAVmed Subsidiary, Veris Health, Announces Launch of Pilot Program with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research InstitutePRNewsWire • 06/13/24